Trevor Snyder, Ph.D. is the Vice President, Artificial Womb Technology. Previously, he was the Vice President, Research & Product Innovation at CorWave, SA in Paris, France leading the research and development of novel circulatory support devices to treat heart failure. Dr. Snyder has over 20 years of experience in the design, development, testing, and clinical use of life-supporting medical devices including heart pumps, artificial lungs, dialysis machines, and bioartificial organs. His pre-clinical and clinical research focused on ensuring adequate perfusion of large animals or humans, including intensive patient monitoring of metabolism, inflammation, coagulation, and respiration. He has served as the PI on four clinical trials, has authored over 25 peer-reviewed manuscripts, and is an inventor on 5 patents with several applications pending. Dr. Snyder has also conducted research investigating cardiac stem cell biology, microfluidics, and xenotransplantation.
He received his Ph.D. in Bioengineering from the University of Pittsburgh studying the pre-clinical evaluation of thrombosis and hemocompatibility of medical devices in large animal models, and his B.S.E. in Biomedical Engineering from Tulane University.